Inventor · disambiguated record
Yigal P. Goldberg
Also filed as: GOLDBERG YIGAL · GOLDBERG YIGAL P · GOLDBERG YIGAL PAUL
14 granted patents·7 pending applications·143 citations·filing 2003–2016
92Inventor score
Files withXENON PHARMACEUTICALS INC5GOLDBERG YIGAL P3MACDONALD MARCIA L3MACDONALD MARCIA2UNIV CALIFORNIA2
Top patents by PatentIndex Score
21 records- 0195US7534764B2Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelinUNIV CALIFORNIA·Filed 2006·Granted May 19, 2009·74 cites·4 claims
- 0295US7511018B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofXENON PHARMACEUTICALS INC·Filed 2005·Granted Mar 31, 2009·27 cites·18 claims
- 0392US7745407B2Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelinUNIV CALIFORNIA·Filed 2009·Granted Jun 29, 2010·11 cites·7 claims
- 0489US8080651B2Juvenile hemochromatosis gene (HFE2A), expression products and uses thereofGOLDBERG YIGAL P·Filed 2009·Granted Dec 20, 2011·12 cites·35 claims
- 0586US7893206B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofXENON PHARMACEUTICALS INC·Filed 2009·Granted Feb 22, 2011·5 cites·17 claims
- 0683US8410054B2Methods for treating pain by inhibition of the SCN9A channelMACDONALD MARCIA L·Filed 2009·Granted Apr 2, 2013·5 cites·10 claims
- 0782US8507435B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofGOLDBERG YIGAL·Filed 2012·Granted Aug 13, 2013·5 cites·12 claims
- 0873US8252578B2Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereofGOLDBERG YIGAL P·Filed 2011·Granted Aug 28, 2012·1 cites·16 claims
- 0972US9278088B2Methods for identifying analgesic agentsMACDONALD MARCIA·Filed 2013·Granted Mar 8, 2016·1 cites·4 claims
- 1067US2010068803A1Juvenile hemochromatosis gene (HFE2A), expression products and uses thereofGOLDBERG YIGAL P·Filed 2009·Application pending·0 cites
- 1163US7659082B2Methods for identifying analgesic agentsXENON PHARMACEUTICALS INC·Filed 2003·Granted Feb 9, 2010·2 cites·17 claims
- 1260US7759348B2Pyridazine derivatives and their use as therapeutic agentsXENON PHARMACEUTICALS INC·Filed 2008·Granted Jul 20, 2010·0 cites·12 claims
- 1355US9086420B2Methods for identifying analgesic agentsMACDONALD MARCIA L·Filed 2010·Granted Jul 21, 2015·0 cites·8 claims
- 1454US2011021530A1Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disordersXENON PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1550US2007166711A1Juvenile hemochromatosis gene (hfe2a), expression products and uses thereofSAMUELS MARK E·Filed 2004·Application pending·0 cites
- 1649US2011306654A1Methods for identifying analgesic agentsMACDONALD MARCIA L·Filed 2011·Application pending·0 cites
- 1748US7964591B2Pyridazine derivatives and their use as therapeutic agentsNOVARTIS PHARMA AG·Filed 2010·Granted Jun 21, 2011·0 cites·14 claims
- 1846US2016166541A1Methods For Identifying Analgesic AgentsMACDONALD MARCIA·Filed 2016·Application pending·0 cites
- 1944US2010292171A1Competitive Regulation of Hepcidin mRNA by Soluble and Cell-Associated HemojuvelinGANZ TOMAS·Filed 2010·Application pending·0 cites
- 2022US9682033B2Methods of treating postherpetic neuralgia with a topical formulation of a spiro-oxindole compoundTEVA PHARMACEUTICALS INT GMBH·Filed 2016·Granted Jun 20, 2017·0 cites·22 claims
- 2119US2015216794A1Methods of treating pain associated with osteoarthritis of a joint with a topical formulation of a spiro-oxindole compoundIVAX INT GMBH·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →